From the Regenerative Bioengineering and Repair Laboratory, Division of Plastic and Reconstructive Surgery, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles; the Department of Plastic and Reconstructive Surgery, Faculty of Medicine, University of Tsukuba; and the Simpson Querrey Institute and the Departments of Materials Science and Engineering, Chemistry, Medicine, and Biomedical Engineering, Northwestern University
Auto-generated profile, based on publicly available information
Situo Zhou
From the Regenerative Bioengineering and Repair Laboratory, Division of Plastic and Reconstructive Surgery, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles; the Department of Plastic and Reconstructive Surgery, Faculty of Medicine, University of Tsukuba; and the Simpson Querrey Institute and the Departments of Materials Science and Engineering, Chemistry, Medicine, and Biomedical Engineering, Northwestern University
Background: Current common techniques for repairing calvarial defects by autologous bone grafting and alloplastic implants have significant limitations. In this study, we investigated a novel alternative approach to bone repair based on peptide amphiphile (PA) nanofiber gels that are engineered to control the release of vascular endothelial growth factor (VEGF) to recruit circulating stem cells to a site of bone regeneration and facilitate bone healing by bone morphogenetic protein-2 (BMP-2). Methods: VEGF release kinetics from PA gels were evaluated. Chemotactic functional scaffolds (CFS) were fabricated by combining collagen sponges with PA gels containing VEGF. The in vitro and in vivo chemotactic activities of CFS were evaluated by measuring mesenchymal stem cell (MSC) migration. and angiogenic capability of CFS was also evaluated. Large-scale rodent cranial bone defects were created to evaluate bone regeneration after implanting CFS and other control materials. Results: VEGF was released from PA in a controlled-release manner. In vitro migration of MSCs was significantly greater when exposed to CFS compared to control scaffolds. In vivo chemotaxis was evidenced by migration of tracer-labeled MSCs to the CFS. CFS showed significantly increased angiogenesis in vivo. Successful bone regeneration was noted in the defects treated with CFS and BMP-2. Conclusion: Our observations suggest that this bioengineered construct successfully acts as a chemo- attractant for circulating MSCs due to controlled release of VEGF from the PA gels. The CFS may play a role in the future design of clinically relevant bone graft substitutes for large-scale bone defects.